
EXCLUSIVE: Trump’s FDA nominee vows new abortion pill safety review after pressure from Sen Hawley
Food and Drug Administration nominee Dr. Heidi Overton committed to a timeline for a delayed mifepristone safety study, Sen. Josh Hawley's office says.
This story was published by Fox News. Read the full article on their site.
Read the full story at foxnews.com(opens in a new tab)







